Mackay Shields LLC Corcept Therapeutics Inc Transaction History

Mackay Shields LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $1.98 Million - $2.42 Million	-99,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$23.49 - $30.56 $1.54 Million - $2 Million	-65,500 Reduced 39.79%	99,100 $2.36 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $389,296 - $633,360	-23,200 Reduced 12.35%	164,600 $4.31 Million
Q3 2020 Nov 04, 2020	SELL	$12.46 - $19.98 $292,810 - $469,530	-23,500 Reduced 11.12%	187,800 $3.27 Million
Q2 2020 Jul 31, 2020	SELL	$11.0 - $18.26 $281,600 - $467,456	-25,600 Reduced 10.81%	211,300 $3.55 Million
Q1 2020 May 08, 2020	SELL	$10.11 - $14.04 $164,793 - $228,852	-16,300 Reduced 6.44%	236,900 $2.82 Million
Q4 2019 Feb 11, 2020	BUY	$12.06 - $16.96 $3.05 Million - $4.29 Million	253,200 New	253,200 $3.06 Million
Q2 2018 Aug 06, 2018	SELL	$15.3 - $19.69 $754,290 - $970,717	-49,300 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$14.59 - $25.5 $719,287 - $1.26 Million	49,300 New	49,300 $811,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.